Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: Vraylar undopaminergic

Posted by SLS on October 12, 2020, at 22:12:40

In reply to Re: Vraylar SLS, posted by undopaminergic on October 12, 2020, at 0:35:21

> > I was interested in Vraylar because it the ratio of D3/D2 binding is significantly higher than Abilify.
> >
> That is its unique property, and the main one why I was interested in trying it too. That said, blocking dopamine D3 is not necessarily a good idea -- possibly even the opposite. Pramipexole, a D3 *agonist* was the only drug that ameliorated my anhedonia.
> -undopaminergic

Abilify and Vraylar bind to D3/D2 receptors, but they are not full antagonists. They are partial agonists. When Abilify first appeared, Stephen Stahl characterized it a dopamine system stabilizer.

1. High dopamine in the synaptic cleft -> receptors are antagonized.

2. Low dopamine in the synaptic cleft -> receptors are stimulated.

It sounds weird, but I imagine there is some kind of conformational change in the receptor at high versus low dopamine concentrations. The postsynaptic dopamine receptor actually has two distinct states that have different binding affinities. This might explain the dual action of partial agonists.

- Scott

Some see things as they are and ask why.
I dream of things that never were and ask why not.

The only thing necessary for the triumph of evil is that good men do nothing.




Post a new follow-up

Your message only Include above post

Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.


Start a new thread

Google www
Search options and examples
[amazon] for

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:SLS thread:1112252